The role of integrating palliative care with systemic anticancer treatment at end-of-life: A single center experience.
Janus Kinase inhibitors (JAKis) are approved for the management of several chronic inflammatory diseases, from rheumatic conditions, to dermatological and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback